Introduction
Subjects and methods
Study sample
Clinical evaluation
Laboratory analyses
Assessment of dietary intake
Statistical analyses
Total | T1 ≤ 28.26 µg/L | T2 >28.26–40.28 µg/L | T3 ≥ 40.29 µg/L | P* | |
---|---|---|---|---|---|
n (% male)a | 899 (57) | 299 (62) | 300 (55) | 300 (54) | 0.106 |
Plasma concentration of boron (µg/L)b | 33.80 (25.61; 44.65) | 22.76 (19.45; 25.61) | 33.79 (30.84; 37.08) | 51.06 (44.64; 61.30) | <0.001 |
Age (years)c | 61 ± 13 | 54 ± 13 | 62 ± 11 | 65 ± 11 | <0.001 |
Body mass index (kg/m2)c | 27.4 ± 4.7 | 28.4 ± 5.5 | 27.2 ± 4.2 | 26.6 ± 4.2 | <0.001 |
Waist circumference (cm)c | |||||
Male | 100.9 ± 11.3 | 101.9 ± 12.3 | 100.6 ± 10.5 | 100.0 ± 10.7 | 0.285 |
Female | 90.9 ± 13.8 | 93.3 ± 15.5 | 91.2 ± 13.3 | 88.6 ± 12.5 | 0.026 |
Waist-to-hip ratioc | |||||
Male | 0.99 ± 0.07 | 0.99 ± 0.07 | 0.99 ± 0.06 | 0.98 ± 0.06 | 0.428 |
Female | 0.88 ± 0.08 | 0.88 ± 0.08 | 0.87 ± 0.07 | 0.88 ± 0.08 | 0.835 |
C-reactive protein (mg/L)b | 1.20 (0.45; 2.60) | 1.40 (0.45; 3.10) | 1.20 (0.45; 2.70) | 1.15 (0.45; 2.10) | 0.137 |
Estimated glomerular filtration rate (mL/min/1.73 m2)c | 84.5 ± 15.2 | 91.4 ± 13.5 | 83.6 ± 14.0 | 78.5 ± 15.3 | <0.001 |
Plasma creatinine concentration (mg/dL)c | 0.88 ± 0.18 | 0.86 ± 0.16 | 0.88 ± 0.17 | 0.92 ± 0.21 | <0.001 |
HbA1c (%)c | 5.7 ± 0.6 | 5.7 ± 0.7 | 5.7 ± 0.6 | 5.8 ± 0.6 | 0.272 |
Plasma glucose concentration (mg/dL)b | 98.0 (91.0; 105.0) | 95.0 (89.0; 104.0) | 98.5 (91.5; 105.0) | 99.0 (93.0; 105.0) | <0.001 |
Prevalent diabetesa | 81 (9.0) | 28 (9.4) | 21 (7.0) | 32 (10.7) | 0.282 |
Glucose-lowering medication (yes/no)a | 38 (4.2)/861 (95.8) | 11 (3.7)/288 (96.3) | 12 (4.0)/288 (96.0) | 15 (5.0)/285 (95.0) | 0.704 |
Plasma triglyceride concentration (mg/dL)b | 105.0 (77.0; 140.0) | 107.0 (78.0; 144.0) | 103.0 (75.5; 136.5) | 104.5 (76.5; 140.0) | 0.364 |
Plasma high-density lipoprotein cholesterol concentration (mg/dL)c | 65.0 ± 18.1 | 60.9 ± 15.9 | 65.6 ± 17.9 | 68.6 ± 19.6 | <0.001 |
Plasma low-density lipoprotein cholesterol concentration (mg/dL)c | 131.3 ± 33.5 | 129.0 ± 32.3 | 134.3 ± 34.2 | 130.7 ± 33.7 | 0.141 |
Lipid-lowering medication (yes/no)a | 118 (13.1)/781 (86.9) | 28 (9.4)/271 (90.6) | 44 (14.7)/256 (85.3) | 46 (15.3)/254 (84.7) | 0.060 |
Systolic blood pressure (mmHg)c | 84.8 ± 9.0 | 139.4 ± 17.3 | 139.2 ± 18.6 | 140.8 ± 19.2 | 0.518 |
Diastolic blood pressure (mmHg)c | 139.8 ± 18.4 | 85.0 ± 9.1 | 84.5 ± 8.9 | 84.9 ± 8.9 | 0.821 |
Antihypertensive medication (yes/no)a | 222 (24.7)/677 (75.3) | 46 (15.4)/253 (84.6) | 78 (26.0)/222 (74.0) | 98 (32.7)/202 (67.3) | <0.001 |
Prevalent hypertensiona | 563 (62.6) | 182 (60.9) | 181 (60.3) | 200 (66.7) | 0.206 |
Current smokersa | 125 (13.9) | 57 (19.1) | 42 (14.0) | 26 (8.7) | 0.002 |
Alcohol intake (g/day)b | 8.9 (3.2; 18.4) | 6.8 (2.6; 16.0) | 8.1 (3.2; 15.7) | 12.3 (4.5; 21.9) | <0.001 |
Physical activity (MET-hours/week)b | 89.0 (57.6; 130.5) | 80.1 (50.0; 121.3) | 92.0 (59.6; 130.5) | 93.6 (60.4; 139.3) | 0.012 |
Education level (low [< 10 years], medium [10 years], high [≥ 11 years])a | 314 (34.9)/293 (32.6)/292 (32.5) | 113 (37.8)/98 (32.8)/88 (29.4) | 112 (37.3)/93 (31.0)/95 (31.7) | 102 (34.0)/89 (29.7)/109 (36.3) | 0.179 |
Plasma phosphate concentration (mg/L)c | 141.0 ± 20.3 | 136.3 ± 19.5 | 141.6 ± 20.1 | 145.2 ± 20.4 | <0.001 |
Plasma magnesium concentration (mg/L)c | 20.5 ± 1.7 | 20.4 ± 1.7 | 20.6 ± 1.6 | 20.6 ± 1.8 | 0.208 |
Plasma calcium concentration (mg/L)c | 97.9 ± 7.2 | 97.1 ± 7.0 | 98.0 ± 7.2 | 98.7 ± 7.4 | 0.023 |
Spring (n = 167) | Summer (n = 168) | Autumn (n = 224) | Winter (n = 340) | P* | |
---|---|---|---|---|---|
Plasma concentration of boron (µg/L) | 33.8 (26.0; 43.3) | 36.9 (28.7; 48.3) | 35.4 (26.4; 47.2) | 31.4 (23.4; 42.3) | 0.002 |
Calculation of plant-based diet indices
Dietary pattern derivation by reduced rank regression
Regression models with dietary indices/pattern
Interaction analysis
Anthropometric and cardio-metabolic correlates of circulating boron
Restricted cubic splines regression
Power calculations
Results
Participant characteristics
Nutritional correlates of circulating boron
Reduced rank regression factor loading | |
---|---|
Overall | |
Explained variance in food intake (%) | 5.0 |
Explained variance in response variable (plasma boron concentration) (%) | 29.5 |
Food group (g/day) | |
Potatoes | – |
Leafy vegetables | – |
Fruiting vegetables | – |
Root vegetables | – |
Cabbage | – |
Other vegetables | – |
Legumes | – |
Fruits | 0.2484 |
Nuts and seeds | 0.2591 |
Milk | – |
Dairy products | – |
Cheese | – |
Bread | −0.1973 |
Pasta and rice | – |
Other cereals (flour, flakes, starches, semolina, dough and pastry, breakfast cereals) | – |
Beef | – |
Pork | – |
Poultry | −0.2339 |
Processed meat | −0.2122 |
Other meat (offals, hash, other meat) | – |
Fish, fish products | – |
Eggs | – |
Butter | – |
Margarine | −0.2146 |
Vegetable oils | – |
Other fats | – |
Sugar products (e.g. syrups, candy, ice cream, desserts) | – |
Chocolate, sweets | −0.1725 |
Cake, cookies | – |
Non-alcoholic beverages | – |
Soft drinks | −0.4040 |
Coffee | |
Tea | 0.1670 |
Beer | – |
Wine | 0.3805 |
Other alcoholic beverages | – |
Sauces | −0.1516 |
Soups | – |
Bouillon | – |
Soya products | – |
Dietetic products | – |
Snacks | −0.2458 |
Least square mean and 95% CI in plasma boron concentrations by tertiles of plant-based diet indices | Percentage change (estimate and 95% CI) in plasma boron concentrations per 10-point increase in plant-based diet indices | ||||
---|---|---|---|---|---|
T1 | T2 | T3 | β (95% CI)a | P* | |
Plant-based diet index | |||||
Model 1 | 32.9 (31.5; 34.4) | 33.9 (32.3; 35.5) | 36.6 (35.1; 38.2) | 8.7 (4.2; 13.3) | <0.001 |
Model 2 | 33.0 (31.5; 34.5) | 33.9 (32.4; 35.5) | 37.3 (35.6; 39.0) | 9.6 (5.0; 14.4) | <0.001 |
Model 3 | 32.9 (31.5; 34.5) | 34.0 (32.5; 35.6) | 36.8 (35.2; 38.5) | 8.7 (4.2; 13.4) | <0.001 |
Healthy plant-based diet index | |||||
Model 1 | 31.9 (30.5; 33.4) | 34.2 (32.8; 35.7) | 37.6 (36.0; 39.4) | 11.5 (7.8; 15.4) | <0.001 |
Model 2 | 32.2 (30.7; 33.7) | 34.8 (33.3; 36.3) | 37.7 (36.0; 39.6) | 11.2 (7.4; 15.2) | <0.001 |
Model 3 | 32.2 (30.8; 33.7) | 34.7 (33.2; 36.2) | 37.4 (35.7; 39.2) | 10.4 (6.6; 14.3) | <0.001 |
Unhealthy plant-based diet index | |||||
Model 1 | 36.6 (35.0; 38.3) | 35.4 (33.9; 36.9) | 31.7 (30.4; 33.1) | −8.5 (−11.7; −5.2) | <0.001 |
Model 2 | 36.9 (35.2; 38.7) | 35.4 (33.9; 37.0) | 32.1 (30.6; 33.6) | −8.7 (−12.1; −5.2) | <0.001 |
Model 3 | 36.8 (35.1; 38.5) | 35.4 (33.8; 36.9) | 31.9 (30.4; 33.4) | −8.8 (−12.1; −5.4) | <0.001 |
Association of plasma boron concentrations with cardio-metabolic traits
Percentage change (estimate and 95% CI) in plasma boron concentrations | ||||
---|---|---|---|---|
β (95% CI) | P* | Poverallǂ | Pnonlinearǂ | |
Age (per 5 year increase)a | 4.79 (3.43; 6.16) | – | <0.001 | 0.845 |
Men (vs. women)b | −2.29 (−7.47; 3.18) | 0.404 | – | – |
Body mass index (per 3 kg/m2 increase)a | −2.84 (−4.53; −1.12) | – | 0.002 | 0.101 |
C-reactive protein (per 50% increase)b | −1.13 (−2.09; −0.17) | – | 0.025 | 0.140 |
Estimated glomerular filtration rate (per 10 ml/min/1.73 m2 increase)a | −5.87 (−7.68; −4.02) | – | <0.001 | 0.014 |
Plasma triglyceride concentration (per 10% increase)b | −1.50 (−2.18; −0.81) | – | <0.001 | 0.067 |
Plasma high-density lipoprotein cholesterol concentration (per 5 mg/dL increase)a | −1.28 (−2.42; −0.14) | – | 0.029 | 0.127 |
Plasma low-density lipoprotein cholesterol concentration (per 10 mg/dL increase)a | −2.12 (−2.93; −1.29) | – | <0.001 | 0.629 |
Plasma total phosphate concentration (per 15 mg/L increase)a | 13.24 (9.88; 16.71) | – | <0.001 | 0.711 |
High education level (vs. low education level)b | 18.42 (11.67; 25.58) | <0.001 | – | – |
Medium education level (vs. low education level)b | 9.32 (3.3; 15.68) | 0.002 | – | – |
Spring (vs. winter)b | 1.56 (−4.9; 8.46) | 0.644 | – | – |
Summer (vs. winter)b | 9.98 (2.96; 17.49) | 0.005 | – | – |
Fall (vs. winter)b | 1.26 (−4.71; 7.6) | 0.686 | – | – |
Taking antihypertensive medication (vs. taking no antihypertensive medication)b | 9.54 (3.03; 16.46) | 0.004 | – | – |